rs34252199

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_015404.4(WHRN):​c.1515G>A​(p.Ala505Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0438 in 1,614,046 control chromosomes in the GnomAD database, including 1,705 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.031 ( 89 hom., cov: 31)
Exomes 𝑓: 0.045 ( 1616 hom. )

Consequence

WHRN
NM_015404.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -5.31

Publications

9 publications found
Variant links:
Genes affected
WHRN (HGNC:16361): (whirlin) This gene is thought to function in the organization and stabilization of sterocilia elongation and actin cystoskeletal assembly, based on studies of the related mouse gene. Mutations in this gene have been associated with autosomal recessive non-syndromic deafness and Usher Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
WHRN Gene-Disease associations (from GenCC):
  • Usher syndrome type 2D
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • autosomal recessive nonsyndromic hearing loss 31
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 9-114423425-C-T is Benign according to our data. Variant chr9-114423425-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 45655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.31 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0524 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WHRNNM_015404.4 linkc.1515G>A p.Ala505Ala synonymous_variant Exon 7 of 12 ENST00000362057.4 NP_056219.3 Q9P202-1B9EGE6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WHRNENST00000362057.4 linkc.1515G>A p.Ala505Ala synonymous_variant Exon 7 of 12 1 NM_015404.4 ENSP00000354623.3 Q9P202-1

Frequencies

GnomAD3 genomes
AF:
0.0309
AC:
4698
AN:
152052
Hom.:
89
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0102
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0326
Gnomad ASJ
AF:
0.0135
Gnomad EAS
AF:
0.00367
Gnomad SAS
AF:
0.0270
Gnomad FIN
AF:
0.0109
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0490
Gnomad OTH
AF:
0.0301
GnomAD2 exomes
AF:
0.0306
AC:
7700
AN:
251446
AF XY:
0.0312
show subpopulations
Gnomad AFR exome
AF:
0.00800
Gnomad AMR exome
AF:
0.0219
Gnomad ASJ exome
AF:
0.0124
Gnomad EAS exome
AF:
0.00223
Gnomad FIN exome
AF:
0.0126
Gnomad NFE exome
AF:
0.0477
Gnomad OTH exome
AF:
0.0305
GnomAD4 exome
AF:
0.0451
AC:
65939
AN:
1461876
Hom.:
1616
Cov.:
32
AF XY:
0.0445
AC XY:
32343
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00803
AC:
269
AN:
33480
American (AMR)
AF:
0.0222
AC:
992
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0106
AC:
278
AN:
26136
East Asian (EAS)
AF:
0.00589
AC:
234
AN:
39700
South Asian (SAS)
AF:
0.0250
AC:
2158
AN:
86258
European-Finnish (FIN)
AF:
0.0150
AC:
800
AN:
53420
Middle Eastern (MID)
AF:
0.0224
AC:
129
AN:
5766
European-Non Finnish (NFE)
AF:
0.0528
AC:
58715
AN:
1111998
Other (OTH)
AF:
0.0391
AC:
2364
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3793
7586
11380
15173
18966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2168
4336
6504
8672
10840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0309
AC:
4696
AN:
152170
Hom.:
89
Cov.:
31
AF XY:
0.0295
AC XY:
2197
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0101
AC:
421
AN:
41528
American (AMR)
AF:
0.0326
AC:
498
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
47
AN:
3470
East Asian (EAS)
AF:
0.00387
AC:
20
AN:
5164
South Asian (SAS)
AF:
0.0270
AC:
130
AN:
4818
European-Finnish (FIN)
AF:
0.0109
AC:
116
AN:
10604
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0490
AC:
3330
AN:
67980
Other (OTH)
AF:
0.0294
AC:
62
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
234
468
703
937
1171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0374
Hom.:
66
Bravo
AF:
0.0304
Asia WGS
AF:
0.0260
AC:
90
AN:
3478
EpiCase
AF:
0.0442
EpiControl
AF:
0.0443

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 25, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 12, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 12, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 31 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Usher syndrome type 2D Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.48
DANN
Benign
0.67
PhyloP100
-5.3
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34252199; hg19: chr9-117185705; API